LY2963016 Insulin Glargine and Insulin Glargine (Lantus) Produce Comparable Pharmacokinetics and Pharmacodynamics at Two Dose Levels

Zhang, X; Lam, ECQ; Seger, ME; Coutant, D; Chua, L; Tan, LH; Soon, D; Linnebjerg, H

Linnebjerg, H (reprint author), Eli Lilly & Co, Indianapolis, IN 46285 USA.

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017; 6 (6): 556

Abstract

LY2963016 (LY IGlar) and Lantus (IGlar) are insulin glargine products with identical amino acid sequences. This was a phase 1 single-site, randomized,......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索